Why Charlie's Holdings CHUC Could Be A MUST OWN Penny Stock

Charlie’s Holdings OTCQB CHUC Insiders Invest Heavy Before FDA Guidance

CHUC Insiders have invested a massive amount of money just weeks before FDA draft guidance.

OTCQB: CHUC

Here’s what investors are missing.

This gives us more insight into why insiders have been buying so much stock on the open market and why they invested another $270,000 in a CHUC private placement last month.

The U.S. Food and Drug Administration draft guidance is a big deal for Charlie’s because it finally shows the industry what winning looks like.

For years, companies were guessing what the FDA wanted. Now it’s clear.

If you can prove your vape device prevents underage use, you have a real shot at FDA approval, even for flavored nicotine products. 

That turns compliance from a guessing game into a technology challenge, and CHUC is already addressing it… likely years ahead of Big Tobacco.

The FDA guidance specifically highlights “device-level age verification,” not just checking ID at a store. 

This plays directly into CHUC’s partnership with IKE Tech LLC, which has built a patented system that literally will not allow the device to function unless and until the adult user is age-verified. 

In simple terms, while others are still trying to convince regulators, CHUC can already show them a working solution.

Age-gating unlocks a massive market opportunity. Most of the flavored vape market today is illicit.

The FDA is essentially saying, “If you can make this safe and inaccessible to youth, you can sell it legally.” 

This guidance creates a pathway to shift billions of dollars in demand toward compliant players, and CHUC is positioned early.

Here’s the real edge.

CHUC isn’t waiting on approvals to start.

Its SBX platform enables CHUC to deploy and to actually prove the technology … to model user behavior with real market data, and to refine the system before nicotine products scale. 

AND… CHUC could also elect to add age-gating to some of its existing PMTAs.

We know CHUC has more than 650 PMTAs with an imputed value of more than $650M… and that’s even BEFORE the applications are amended to include age-gating.

All of this helps explain why one of the world’s biggest tobacco companies was such an aggressive buyer of a handful of CHUC’s PMTAs last year.

So… the FDA draft guidance isn’t just a regulation. It’s validation.  

Just The Agency’s guidance confirms that the exact path CHUC chose — combining compliant tech with forward-looking flavored products that adult consumers actually prefer — could be precisely the strategy that regulators reward.

Bottom Line:  Charlie’s Holdings Inc., ticker symbol CHUC, is one of the few companies building exactly what regulators are asking for.

And why Charlie’s Holdings CHUC could be a must own penny stock.

Other Articles About Charlie’s Holdings OTCQB:CHUC

• OTCQB:CHUC Best Nicotine Vape Stock
• Best Profitable Penny Stock for 2026
• Is CHUC The Next MNST Monster Beverage?
• Big Tobacco Quietly Acquires CHUC PMTAs
• OTCQB:CHUC Investor Deck
• CHUC’s Latest Shareholder Letter
• Charlie’s Holdings OTCQB: CHUC Oct 2025 Interview
• CHUC Launches SBX Product Delivers 336% Q3 Revenue Growth
• BEST Profitable Penny Stock With Insider Buying
• IKE Tech and CHUC Partner for FIRST US Age Gating System
• Charlies Holdings Investor Summary 2026

Safe Harbor Statement: This interview contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements regarding the Company’s overall business, existing and anticipated markets and expectations regarding future sales and expenses. Words such as “expect,” “anticipate,” “should,” “believe,” “target,” “project,” “goals,” “estimate,” “potential,” “predict,” “may,” “will,” “could,” “intend,” variations of these terms or the negative of these terms, and similar expressions, are intended to identify these forward-looking statements. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ongoing ability to quote its shares on the OTCQB; whether the Company will meet the requirements to up-list to a national securities exchange in the future; the Company’s ability to successfully increase sales and enter new markets; whether the Company’s PMTA’s for its nicotine-containing products will be authorized by the FDA, and the FDA’s decisions with respect to the Company’s future PMTA’s for nicotine products; the Company’s ability to manufacture and produce products for its customers; the Company’s ability to formulate new products; the acceptance of existing and future products; the complexity, expense and time associated with compliance with government rules and regulations affecting nicotine, synthetic nicotine, and products containing nicotine substitutes; litigation risks from the use of the Company’s products; risks of government regulations; the impact of competitive products; and the Company’s ability to maintain and enhance its brands, as well as other risk factors included in the Company’s most recent quarterly report on Form 10-Q, annual report on Form 10-K, and other SEC filings. These forward-looking statements are made as of the date of this interview and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this interview as a result of new information, future events or changes in its expectations.

Artificial Intelligence Stock Reading

• The Best Artificial Intelligence Penny Stock VERSES AI
• Artificial Intelligence Stock with BIGGEST Potential
• What is BETTER than ChatGPT Generative Artificial Intelligence
• Generative Artificial Intelligence Regulation Solution
• How To Govern and Regulate Artificial Intelligence
• The BEST C3 AI Stock Alternative
• Next Generation Intelligence Patent Application
• The ONLY Adaptive Artificial Intelligence Stock
• Artificial Intelligence Stocks
• VERSES VRSSF 2023 Year End Summary
• The Story of VERSES AI VRSSF
• How VERSES AI Solves the Generative AI Problem